Anthony W. Shaw

Discovery of an Anion-Dependent Farnesyltransferase Inhibitor from a Phenotypic Screen.

Peter S. Kutchukian, A. W. Shaw, Jing Li, 2020, ACS medicinal chemistry letters.

Dual protein farnesyltransferase-geranylgeranyltransferase-I inhibitors as potential cancer chemotherapeutic agents.

A. W. Shaw, T. Ciccarone, L. Beese, 2003, Journal of medicinal chemistry.